Dr. Yanan Dai is an interdisciplinary researcher specializing in medical artificial intelligence, cardiovascular medicine, health services research, causal inference, and healthcare data science. With a strong foundation in both engineering and healthcare research, Dr. Dai has successfully integrated advanced artificial intelligence techniques with clinical medicine to address complex challenges in cardiovascular disease diagnosis, immune-related cardiac toxicity, clinical decision support, and healthcare policy.

Prior to entering full-time research, Dr. Dai worked at Honeywell Life Safety Group as a Software Engineer (2008–2012) and later as a Project Management Engineer (2012–2015), gaining extensive experience in software development, system integration, and project management. This industrial experience has significantly contributed to the development of innovative AI-based healthcare solutions.

Dr. Dai possesses strong technical expertise in Python, R, SQL Server, MATLAB, machine learning, deep learning, causal reinforcement learning, and healthcare analytics. Additionally, Dr. Dai is a certified System Integration Project Management Engineer and has excellent English proficiency (CET-4, CET-6, IELTS 6.5).

Research Expertise

Dr. Dai's research focuses on the intersection of artificial intelligence, clinical medicine, and healthcare systems, particularly in:

• Medical Artificial Intelligence and Deep Learning
• Cardiovascular Disease Diagnosis and Prognosis
• Coronary Angiography and CABG Decision Support
• Immune Checkpoint Inhibitor (ICI)-Related Myocarditis
• Clinical Decision Support Systems
• Causal Inference and Reinforcement Learning
• Medical Image Analysis
• Healthcare Services Research
• Health Economics and Insurance Policy
• Technology Transfer Prediction
• Medical Big Data and Privacy Protection
• Decentralized AI and Federated Learning
• Healthcare Resource Optimization

Research Contributions

Dr. Dai has established an innovative multidisciplinary research portfolio combining AI methodologies, causal inference frameworks, and healthcare system analysis.

Major scientific contributions include:

• Development of novel unsupervised language model approaches for coronary angiography interpretation and CABG indication prediction.
• Creation of AI-driven risk prediction models for immune-related myocarditis and optimal therapeutic intervention timing.
• Comparative evaluation of Transformer, RNN, CNN, and causal reinforcement learning frameworks for clinical outcome prediction.
• Research on healthcare payment reform, physician behavior, patient selection bias, and medical resource allocation.
• Development of decentralized AI frameworks to overcome medical data silos.
• Machine learning models predicting technology commercialization success and healthcare innovation transfer.
• Advancement of explainable and clinically applicable AI systems for cardiovascular medicine.

These contributions bridge engineering innovation with real-world clinical applications, supporting precision medicine and evidence-based healthcare management.

Publications and Academic Achievements

Dr. Dai has authored numerous high-impact publications as First Author in internationally recognized journals.

Highlights include publications in:

• International Journal of Surgery
• Scientific Reports (Nature Portfolio)
• Quantitative Imaging in Medicine and Surgery
• BMC Health Services Research
• Discover Artificial Intelligence
• Chinese Clinical Medicine

Several additional manuscripts are currently under review in prestigious journals including:

• npj Digital Medicine
• Humanities & Social Sciences Communications
• BMC Medical Informatics and Decision Making
• IEEE Journal of Biomedical and Health Informatics

The research covers medical AI, cardiovascular imaging, causal machine learning, health policy, medical robotics, and technology transfer.

Innovation, Patents & Software Development

Dr. Dai has demonstrated exceptional innovation through numerous intellectual property achievements, including:

• Multiple medical AI patents related to privacy-preserving medical knowledge transfer, myocarditis prediction, machine learning-based technology commercialization, and multimodal clinical prediction.
• Development of software systems including:
  • Coronary Artery SYNTAX Scoring Program
  • AI-assisted Coronary Visualization Tool
  • Medical Record Information Extraction System
  • Structured Medical Record Conversion System
  • Transformer-based Mortality Prediction System
  • Clinical Database Online Analysis Platform
  • Myocarditis Treatment Prediction System

These innovations translate cutting-edge research into practical healthcare technologies.

Awards & Recognition

Dr. Dai has received international recognition for research excellence, including:

• Research Excellence Award – International Popular Scientist Awards (2026)
• International Academic Award

These honors recognize significant contributions to artificial intelligence, healthcare innovation, and translational medical research.

Professional Strengths

• Interdisciplinary expertise spanning engineering, medicine, and health economics.
• Strong leadership in AI model development and collaborative research.
• Extensive experience in clinical data analytics and predictive modeling.
• High-level scientific writing with numerous first-author publications.
• Proven capability in translating research into patented technologies and software products.
• Commitment to advancing precision medicine through innovative computational approaches.

Eligibility for Innovative Researcher of the Year

Dr. Yanan Dai is highly eligible for the Innovative Researcher of the Year Award in Scientific Laurels. Dr. Dai's outstanding profile is distinguished by pioneering interdisciplinary research that integrates artificial intelligence, causal inference, cardiovascular medicine, and healthcare systems to solve complex clinical challenges. With numerous first-author publications in high-impact international journals, several innovative patents, multiple healthcare software copyrights, and internationally recognized research excellence, Dr. Dai has demonstrated exceptional originality, scientific innovation, and translational impact. The development of novel AI-driven diagnostic frameworks, clinical decision-support systems, privacy-preserving healthcare technologies, and predictive models for precision medicine exemplifies a sustained commitment to advancing modern healthcare through technological innovation. These significant scientific achievements make Dr. Dai an exceptionally deserving candidate for the Innovative Researcher of the Year Award under the Scientific Laurels program.